Archives

by in
Entry Author Date Location
OvaScience Adds $37M for Fertility Treatments 04/04/12 Boston
OvaScience Uses Stem Cells to Revive Fertility 10/12/11 Boston
Big Pharma Attempts to Extend Own Lifespan by Activating Sirtuins 09/23/11 Boston
Three Kings: Bessemer, Greylock, Summit Raising Big New Funds 03/04/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
Glaxo Ends Resveratrol Drug Study 12/01/10 Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News 08/13/10 Boston
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm 04/21/10 Boston
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug 01/28/10 Boston
Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma 11/13/09 Boston
See You There Tomorrow at Pharma’s Bet on Boston Innovation 11/03/09 Boston
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News 10/28/09 Boston
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes 10/14/09 Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News 09/30/09 Boston
Sirtris’ Westphal and Collaborators Launching New Nonprofit to Help People Live Longer 09/24/09 Boston
Inside a Life Sciences Industry Confab: Notes from Convergence 06/17/09 Boston
The Health 2.0 Hub, Boston’s Secret Entertainment Cluster, A Path to Market for Energy Innovations, Dean Kamen, and more XSITEment 06/02/09 Boston
Elixir Raises $12 Million, Says Drug Trial Could Lead to Novartis Purchase 05/19/09 Boston
GSK biotech subsidiary Tempero Pharma launched in the Boston area 05/15/09 Boston
Bio Bigwigs from Boston and Beyond Gather in Cambridge to Discuss Future of Drug Development, Venture Capital, and Deals with Pharma 04/08/09 Boston
Magen BioSciences Sold for $14.5M, Codon Devices Closing Doors 04/03/09 Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started 03/25/09 Boston
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News 03/25/09 Boston
Ex-Wyeth Exec Named Sirtris Pres. 03/20/09 Boston
The Greater Boston Diabetes Cluster 02/09/09 Boston
Viewers Hunt for Sirtris’ Anti-Aging Drugs After 60 Minutes Story 01/27/09 Boston
Vertex Stays Put, Hydra Handed $22M, Sequenom Still Pursuing Exact Sciences Acquisition, & More Boston-Area Life Sciences News 01/21/09 Boston
Hey Life Sciences Fans, Remember The Deals Back in 2008… 01/05/09 Boston
Novartis Deal Could Boost Ascent by $200M, Ariad’s Boardroom Drama Comes to Light, Targanta Takes Another Hit, & More Boston-Area Life Sciences News 12/10/08 Boston
Glaxo Promotes Sirtris’ Christoph Westphal to Drug Discovery Leadership Role 12/03/08 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.